Fluarix Tetra

Fluarix Tetra is an influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline Biologicals S.A.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the Influenza Virus B/Austria/1359417/2020. It is typically recommended for individuals seeking protection against seasonal flu strains. The vaccine is intended for use in individuals who are at risk of complications from influenza, including the elderly, young children, and those with chronic health conditions.

Common effects of Fluarix Tetra may include soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or muscle aches following vaccination. These effects are usually temporary and resolve within a few days.

Fluarix Tetra should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of the components of Fluarix Tetra should avoid this vaccine. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine.

Fluarix Tetra may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Fluarix Tetra. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.